Abbvie Inc
NYSE:ABBV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
152.1567
216.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Abbvie Inc
Revenue Breakdown
Breakdown by Geography
Abbvie Inc
|
Total Revenue:
56.3B
USD
|
|
United States:
43B
USD
|
|
All Other Countries:
5.4B
USD
|
|
Germany:
1.5B
USD
|
|
Japan:
1.1B
USD
|
|
Canada:
1.1B
USD
|
|
China:
917m
USD
|
|
France:
776m
USD
|
|
Spain:
528m
USD
|
|
United Kingdom:
522m
USD
|
|
Italy:
511m
USD
|
|
Brazil:
464m
USD
|
|
Australia:
463m
USD
|
Breakdown by Segments
Abbvie Inc
|
Total Revenue:
56.3B
USD
|
|
Skyrizi:
11.7B
USD
|
|
Humira:
9B
USD
|
|
Rinvoq:
6B
USD
|
|
Imbruvica:
3.3B
USD
|
|
Botox Therapeutic:
3.3B
USD
|
|
Vraylar:
3.3B
USD
|
|
All Other:
3B
USD
|
|
Botox Cosmetic:
2.7B
USD
|
|
Venclexta:
2.6B
USD
|
|
Creon:
1.4B
USD
|
|
Mavyret:
1.3B
USD
|
|
Other Aesthetics:
1.3B
USD
|
|
Juvederm Collection:
1.2B
USD
|
|
Ubrelvy:
1B
USD
|
|
Linzess/Constella:
954m
USD
|
|
Other Eye Care:
847m
USD
|
|
Qulipta:
658m
USD
|
|
Ozurdex:
494m
USD
|
|
Elahere:
479m
USD
|
|
Duodopa:
447m
USD
|
|
Lumigan/Ganfort:
429m
USD
|
|
Other Neuroscience:
338m
USD
|
|
Alphagan/Combigan:
248m
USD
|
|
Restasis:
224m
USD
|
|
Epkinly:
146m
USD
|
You don't have any saved screeners yet
